Moderna's Covid-19 vaccine shows efficacy of 94.5%, even higher than Pfizer and BioNTech's. Shares up 7% in pre-market trading. https://t.co/QH8SvG8diq— Hannah Kuchler (@hannahkuchler) November 16, 2020
Moderna's Covid-19 vaccine shows efficacy of 94.5%, even higher than Pfizer and BioNTech's. Shares up 7% in pre-market trading. https://t.co/QH8SvG8diq